相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease
Alessandro Tozzi et al.
CELL DEATH & DISEASE (2018)
Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
Jillian H. Kluss et al.
NPJ PARKINSONS DISEASE (2018)
Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
Pawel Lis et al.
BIOCHEMICAL JOURNAL (2018)
Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-κB Inhibition
Zheng-Qiang Zou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
Francesco Longo et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?
Elisa Greggio et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
PDE4B as a Microglia Target to Reduce Neuroinflammation
Damien D. Pearse et al.
GLIA (2016)
Increased Peripheral Inflammation in Asymptomatic Leucine-Rich Repeat Kinase 2 Mutation Carriers
Nicolas Dzamko et al.
MOVEMENT DISORDERS (2016)
siRNA-mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin-stimulated primary cultured microglia
Hao Cheng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
Joao P. L. Daher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2015)
THE COMPLEX RELATIONSHIPS BETWEEN MICROGLIA, ALPHA-SYNUCLEIN, AND LRRK2 IN PARKINSON'S DISEASE
J. Schapansky et al.
NEUROSCIENCE (2015)
LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2014)
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity
Loukia Parisiadou et al.
NATURE NEUROSCIENCE (2014)
cAMP signaling in subcellular compartments
Konstantinos Lefkimmiatis et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3
Kathrin Muda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury
Mousumi Ghosh et al.
GLIA (2012)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Spatial control of cAMP signalling in health and disease
Manuela Zaccolo
CURRENT OPINION IN PHARMACOLOGY (2011)
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
Veronique Daniels et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
Xianting Li et al.
PLOS ONE (2011)
Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases
George S. Baillie
FEBS JOURNAL (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Phosphorylation of the cAMP-dependent protein kinase (PKA) regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in cardiac cells
Sabrina Manni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system - A molecular toolbox for generating compartmentalized cAMP signaling
Miles D. Houslay et al.
CIRCULATION RESEARCH (2007)
The Parkinson disease gene LRRK2:: Evolutionary and structural insights
Ignacio Marin
MOLECULAR BIOLOGY AND EVOLUTION (2006)
Distribution of PINK1 and LRRK2 in rat and mouse brain
Jean-Marc Taymans et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
C Lugnier
PHARMACOLOGY & THERAPEUTICS (2006)
LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain
J Simón-Sánchez et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor -: art. no. e65
S Goldwurm et al.
JOURNAL OF MEDICAL GENETICS (2005)
The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways
KL Dodge-Kafka et al.
NATURE (2005)
DNA binding of repressor nuclear factor-κB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit
HC Guan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Localized effects of cAMP mediated by distinct routes of protein kinase A
K Tasken et al.
PHYSIOLOGICAL REVIEWS (2004)
Phosphorylation of serine 337 of NF-κB p50 is critical for DNA binding
SH Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression of recombinant proteins in a lipid A mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation
I Cognet et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Selectivity and regulation of A-kinase anchoring proteins in the heart - The role of autophosphorylation of the type II regulatory subunit of cAMP-dependent protein kinase
DR Zakhary et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
